{
    "Trade/Device Name(s)": [
        "VITROS Immunodiagnostic Products Syphilis Reagent Pack",
        "VITROS Syphilis test"
    ],
    "Submitter Information": "Ortho Clinical Diagnostics",
    "510(k) Number": "K241534",
    "Predicate Device Reference 510(k) Number(s)": [
        "K160910",
        "K211302"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIP"
    ],
    "Summary Letter Date": "May 30, 2024",
    "Summary Letter Received Date": "May 30, 2024",
    "Submission Date": "August 27, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema Pallidum Treponemal Test Reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "Total antibodies (IgG and IgM) to Treponema pallidum specific antigens"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum Separator Tube (SST)",
        "Plasma Separator Tube (PST)",
        "Lithium heparin plasma tube",
        "Sodium heparin plasma tube",
        "K2 EDTA plasma tube",
        "K3 EDTA plasma tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS 5600 Integrated System"
    ],
    "Method(s)/Technology(ies)": [
        "Immunometric sandwich assay",
        "Chemiluminescent detection"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Calibrator",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Syphilis qualitative immunoassay to detect total IgG and IgM antibodies to Treponema pallidum in serum and plasma using VITROS 5600 Integrated System",
    "Indications for Use Summary": "For qualitative determination of total (IgG and IgM) antibodies to Treponema pallidum specific antigens in human serum and plasma to aid in diagnosis of syphilis infection; not intended for blood or tissue donor screening",
    "fda_folder": "Microbiology"
}